# AI Discovery Report: MedTech Solutions

**Prepared by:** [Your Firm]
**Date:** March 2026
**Status:** Pre-engagement draft (to be finalized after stakeholder discovery)
**Version:** 0.1 (Pre-Discovery)

---

## 1. Company Overview

### Company Profile

MedTech Solutions is a mid-market healthcare organization operating a chain of specialty clinics. With approximately 500 employees and $80M in annual revenue, they occupy a common position in the healthcare landscape: large enough to benefit significantly from AI and automation, but without the internal technical capability that major health systems possess.

### Current Technology Landscape

- **IT Team:** 12 staff (lean for 500 employees; likely operationally focused)
- **Infrastructure:** Hybrid on-premises + AWS (in transition, not cloud-native)
- **Patient Intake:** Paper-based (confirmed by CEO)
- **EHR/EMR:** Unknown (critical question for CTO call)
- **Data Architecture:** Presumed immature given paper-based processes

### Competitive Landscape

The specialty clinic market is experiencing rapid AI adoption:
- Major health systems deploying ambient documentation (Nuance DAX, Abridge)
- Digital-first patient intake becoming table stakes (Phreesia, Clearwave)
- AI-powered revenue cycle management gaining traction (Waystar, AKASA)
- Patient engagement platforms reducing no-shows by 10-30% (Luma Health, Artera)

Organizations that delay digitization and AI adoption risk falling behind on operational efficiency, clinician satisfaction, patient experience, and ultimately revenue per visit.

### Regulatory Environment

MedTech Solutions operates under significant regulatory constraints that shape AI adoption:

- **HIPAA:** All AI systems touching Protected Health Information (PHI) must comply. Business Associate Agreements required for all third-party AI vendors.
- **FDA:** AI/ML used in clinical decision support may require clearance. Operational and administrative AI is generally exempt.
- **21st Century Cures Act:** Information blocking rules require interoperability (FHIR, HL7).
- **State Privacy Laws:** May vary by clinic location.
- **Patient Consent:** Use of patient data for AI training beyond treatment may require specific consent.

---

## 2. AI Maturity Assessment

### Dimension Scores

| Dimension | Score | Weight | Weighted | Key Evidence |
| --- | --- | --- | --- | --- |
| Data | 1.5 | 25% | 0.375 | Paper-based intake, likely data silos across clinic locations, no indication of data warehouse or analytics infrastructure |
| Infrastructure | 2.0 | 20% | 0.40 | Hybrid on-prem/AWS indicates partial cloud migration; not cloud-native; no MLOps |
| Talent | 1.5 | 20% | 0.30 | 12-person IT team with no indicated AI/ML skills; team likely consumed by operations |
| Governance | 1.5 | 20% | 0.30 | No AI policy indicated; HIPAA compliance likely exists but not AI-specific |
| Culture | 2.5 | 15% | 0.375 | CEO actively interested and has budget; vague expectations suggest enthusiasm without deep understanding |
| **Aggregate** | **1.8** | | **1.75** | **Foundation Stage** |

### Engagement Stage: Foundation-to-Pilot-Ready

At 1.8, MedTech Solutions is at the upper end of Foundation stage. This means:

- The organization needs data foundations before advanced AI
- However, mature vendor solutions can deliver value immediately without requiring internal AI capability
- The strategy should combine foundational work (digitization, data capture) with quick wins (vendor SaaS solutions)
- Timeline to meaningful AI value: 3-6 months with the right approach

### Gap Analysis

All dimensions are within a relatively narrow range (1.5-2.5), which is typical for organizations beginning their AI journey. The most significant patterns:

- **Culture (2.5) leads all other dimensions.** Executive sponsorship exists. This is favorable -- the biggest barrier (organizational resistance) is not present.
- **Data (1.5) is the critical bottleneck.** Paper-based processes mean patient data is not captured in structured, accessible formats. This must be addressed in Phase 1.
- **Talent (1.5) and Governance (1.5) are tied constraints.** The organization cannot build AI internally and lacks the governance frameworks to deploy it safely. Both are addressable through vendor solutions and policy development.

**Bottleneck Pattern:** "High culture, low data" -- has the organizational will but lacks the raw material. This is the most favorable bottleneck pattern because organizational resistance is harder to fix than data infrastructure.

---

## 3. Stakeholder Findings

### Status: Pre-Discovery

Stakeholder interviews have not yet been conducted. The CTO call is scheduled for next week. This section provides the interview plan and will be populated with findings.

### Executive Perspective (To Be Validated)
- CEO wants to "use AI to modernize operations"
- Budget exists but is not defined
- CTO perspective and priorities unknown
- Board/investor expectations unknown

### Anticipated Department Pain Points

Based on industry patterns for specialty clinic chains:

| Department | Likely Pain Points | Expected Priority |
| --- | --- | --- |
| **Clinic Operations** | Paper intake bottlenecks, scheduling complexity, multi-site coordination, staffing challenges | High |
| **Revenue Cycle / Billing** | Coding errors, claim denials, prior auth delays, A/R aging | High |
| **Clinical Staff** | Documentation burden, prior auth paperwork, information lookup, referral management | High |
| **IT** | System maintenance, EHR management, limited bandwidth for new projects, security/compliance | Medium |
| **Front Desk / Admin** | Phone volume, scheduling, patient communication, form processing | Medium |

### Technical Landscape (To Be Validated in CTO Call)

**Known:**
- Hybrid on-prem + AWS infrastructure
- Paper-based patient intake
- 12-person IT team

**Critical Unknowns:**
- EHR/EMR system and version
- AWS services in use (basic hosting vs. managed services)
- Data architecture and integration capabilities
- API availability and maturity
- CI/CD and deployment practices
- Security and compliance certifications held

### Frontline Insights (To Be Gathered During Discovery)

Frontline interviews will focus on:
- Actual time spent on paper intake processing per patient
- Daily workflow friction points for clinic staff
- Clinician documentation hours per day
- Prior authorization burden (hours per week)
- Workarounds and tribal knowledge in current processes

---

## 4. Risk Assessment

### Identified Red Flags

| # | Red Flag | Severity | Status | Mitigation |
| --- | --- | --- | --- | --- |
| 1 | Vague budget | Medium | Open | Get range commitment in CTO/CEO interviews |
| 2 | Potentially unrealistic expectations | Medium-High | Open | Anchor with industry benchmarks; frame Phase 1 as foundation |
| 3 | No data strategy / low data readiness | High | Assumed | Digitization as Phase 1; validate in CTO call |
| 4 | Compliance/legal not consulted on AI | Medium | Assumed | Include in stakeholder interviews; add to Phase 1 |
| 5 | No physician champion identified | Medium | Unknown | Identify during discovery; scope initial projects accordingly |
| 6 | IT team capacity constraints | Medium | Likely | Buy-over-build strategy; include implementation support in SOW |

### Overall Risk Assessment

No critical (engagement-killing) red flags identified. The risk profile is typical for a healthcare organization at this maturity level. All identified risks have clear mitigation paths. The CTO call next week will validate or resolve most open items.

---

## 5. Opportunity Matrix

### Quick Wins (High Impact, High Feasibility)

#### Digital Patient Intake
- **Impact:** 5 | **Feasibility:** 5 | **Score:** 25
- Replace paper forms with digital intake platform (Phreesia, Yosi Health, Clearwave)
- Deploy in 30-60 days across all clinics
- Estimated annual value: $150K-$300K
- Critical enabler: creates structured data for all downstream AI initiatives
- **Build vs Buy:** Buy -- mature vendor market
- **GenAI vs Traditional:** Neither -- this is digitization/SaaS, but it is the AI prerequisite

#### AI Patient Communication Agent
- **Impact:** 4 | **Feasibility:** 4 | **Score:** 16
- Automated appointment reminders, pre/post-visit communication, routine inquiries
- Deploy in 60-90 days
- Estimated annual value: $200K-$400K
- Reduces no-shows 10-30%, frees front-desk staff
- **Build vs Buy:** Buy -- healthcare-specific vendors available (Luma Health, Artera)
- **GenAI vs Traditional:** GenAI/Agent -- LLM-powered natural language interactions

### Strategic Bets (High Impact, Lower Feasibility)

#### Ambient Clinical Documentation
- **Impact:** 5 | **Feasibility:** 3 | **Score:** 15
- AI-powered clinical note generation from patient encounters
- 3-4 month pilot timeline
- Estimated annual value: $500K-$1.2M at scale
- Requires physician champion, EHR integration, workflow change
- **Build vs Buy:** Buy -- specialized vendor products (Nuance DAX, Abridge, Nabla)
- **GenAI vs Traditional:** GenAI -- LLM transcription and summarization

#### Medical Coding AI
- **Impact:** 4 | **Feasibility:** 3 | **Score:** 12
- AI-assisted coding suggestions, error flagging, denial reduction
- Depends on digitized documentation from other initiatives
- Estimated annual value: $250K-$500K
- **Build vs Buy:** Buy (Waystar, AKASA, 3M)

#### Prior Authorization Automation
- **Impact:** 4 | **Feasibility:** 2 | **Score:** 8
- AI agent for prior auth submission, evidence extraction, status tracking
- Complex integration with payer systems; vendor market still maturing
- Estimated annual value: $300K-$600K
- **Build vs Buy:** Buy with customization (Cohere Health, Infinitus)

### Fill-Ins

#### Referral Management Automation (Impact: 3, Feasibility: 3, Score: 9)
#### Operational Analytics Dashboard (Impact: 3, Feasibility: 2, Score: 6)

---

## 6. Recommended Roadmap

### Phase 1: Foundation and Quick Wins (Month 1-3)

**Goal:** Digitize core workflows, demonstrate AI value, build data foundation

| Workstream | Description | Timeline | Investment |
| --- | --- | --- | --- |
| Digital Patient Intake | Deploy across all clinics | Month 1-2 | $30K-$80K impl |
| Patient Communication Agent | Deploy for scheduling and reminders | Month 1-3 | $50K-$100K impl |
| AI Governance Foundation | Establish AI use policy, vendor review process, HIPAA AI compliance | Month 1-3 | Internal effort |
| Data Inventory | Catalog data assets across all systems and locations | Month 2-3 | $15K-$25K consulting |

**Milestones:**
- Month 1: Digital intake vendor selected and configured; communication agent vendor selected
- Month 2: Digital intake live at first clinic(s); communication agent in pilot
- Month 3: Digital intake rolled out to all clinics; communication agent fully deployed; Phase 2 go/no-go decision

**Success Metrics:**
- Patient check-in time reduced by 50%+
- Data entry errors reduced by 80%+
- No-show rate reduced by 10%+
- Staff hours saved: 20+ hours/week across all clinics

**Estimated Investment:** $95K-$205K implementation + $70K-$140K/year ongoing
**Estimated Annual Return:** $350K-$700K

### Phase 2: Clinical AI Pilot (Month 3-6)

**Goal:** Prove clinical AI value, build internal capability, establish governance

| Workstream | Description | Timeline | Investment |
| --- | --- | --- | --- |
| Ambient Documentation Pilot | Deploy with 5-10 clinicians at 1-2 locations | Month 3-5 | $100K-$200K impl |
| AI Governance Maturation | Formalize model review, bias monitoring, compliance processes | Month 3-6 | Internal + $10K-$20K consulting |
| Data Integration | Connect EHR, intake, billing, and scheduling data streams | Month 4-6 | $40K-$80K consulting |
| Capability Building | Identify and upskill 1-2 IT team members; evaluate AI CoE need | Month 3-6 | $10K-$20K training |

**Milestones:**
- Month 3: Physician champion identified; documentation vendor selected
- Month 4: Pilot launched with first cohort of clinicians
- Month 5: Pilot results measured; clinician feedback collected
- Month 6: Full deployment decision; Phase 3 go/no-go

**Success Metrics:**
- Clinician documentation time reduced by 50%+ for pilot participants
- Clinician satisfaction score for AI tool: 4/5+
- Note quality maintained or improved (measured by coding accuracy)
- No HIPAA or compliance incidents

**Estimated Investment:** $150K-$300K implementation + $80K-$200K/year ongoing
**Estimated Annual Return:** $500K-$1.2M at scale

### Phase 3: Scale and Optimize (Month 6-12)

**Goal:** Expand proven AI, deploy advanced capabilities, build lasting infrastructure

| Workstream | Description | Timeline | Investment |
| --- | --- | --- | --- |
| Documentation Rollout | Expand ambient documentation to all clinicians | Month 6-8 | $50K-$100K rollout |
| Medical Coding AI | Deploy AI-assisted coding and denial reduction | Month 7-10 | $75K-$180K impl |
| Prior Auth Automation | Pilot AI agent for prior authorization | Month 8-12 | $100K-$250K impl |
| Analytics Foundation | Centralized operational analytics across locations | Month 9-12 | $60K-$150K impl |

**Success Metrics:**
- Documentation time savings across all clinicians
- Coding error rate reduced by 30%+
- Prior auth processing time reduced by 40%+
- Executive dashboard operational across all locations

**Estimated Investment:** $285K-$680K implementation
**Estimated Annual Return:** $550K-$1.1M (incremental)

---

## 7. Investment Summary

### Total Estimated Investment (12 Months)

| Category | Year 1 | Annual Ongoing |
| --- | --- | --- |
| Phase 1: Foundation & Quick Wins | $95K-$205K | $70K-$140K |
| Phase 2: Clinical AI Pilot | $150K-$300K | $80K-$200K |
| Phase 3: Scale & Optimize | $285K-$680K | $110K-$270K |
| **Total** | **$530K-$1.19M** | **$260K-$610K** |

### Total Estimated Annual Return (at full run-rate)

| Phase | Estimated Annual Return |
| --- | --- |
| Phase 1 Initiatives | $350K-$700K |
| Phase 2 Initiatives | $500K-$1.2M |
| Phase 3 Initiatives | $550K-$1.1M |
| **Total** | **$1.4M-$3.0M** |

### Payback Analysis

- **Phase 1 alone pays back in 3-5 months** -- lowest risk, highest certainty
- **Cumulative breakeven by month 6-8** of Year 1
- **Year 1 ROI (conservative):** 75-150%
- **Year 2+ ROI:** 200-400% as ongoing costs are lower than Year 1 and benefits compound

Each phase includes a go/no-go decision point. The organization can stop after any phase and still have realized meaningful value.

---

## Appendices

### A: Interview Plan and Schedule
See `stakeholder-discovery.md` for complete interview guides with role-specific questions.

### B: Competitive AI Landscape
Key competitors and market trends documented in `company-briefing.md`.

### C: Technology Assessment Details
AI maturity scores and evidence documented in `ai-maturity-assessment.md`.

### D: Regulatory Considerations
HIPAA, FDA, and healthcare-specific compliance requirements documented in `company-briefing.md` and `red-flags.md`.

### E: Healthcare Industry AI Playbook
Industry-specific opportunities, regulatory constraints, and red flags referenced from the healthcare playbook in the engagement framework.
